Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Cardiology

Stents or Bypass: Choosing the Right Procedure

At a Glance

For coronary atherosclerosis, the choice between a stent and bypass depends on the urgency, blockage complexity, diabetes, surgical risk, and personal preferences. Stents recover faster, while bypass may provide greater durability and fewer repeat procedures in complex disease.

While medications are the foundation of treating coronary atherosclerosis, there are times when an invasive procedure is necessary to restore blood flow to the heart. When this happens, you and your doctors will usually choose between two main options: Percutaneous Coronary Intervention (PCI), also known as stenting, and Coronary Artery Bypass Grafting (CABG), commonly called bypass surgery [1].

It is important to understand that both PCI and CABG treat selected flow-limiting lesions rather than eliminating the underlying atherosclerotic tendency. Preventive medication and lifestyle changes must continue long after either procedure.

The “Heart Team” Approach

For complex cases, modern guidelines recommend a Heart Team approach [1]. This is a collaborative group that includes an interventional cardiologist, a cardiac surgeon, and a general cardiologist [2]. Their goal is to look at your unique anatomy, your overall health, kidney function, and your personal preferences to recommend the safest and most effective strategy for you [3][4].

Understanding Your Options

  • Stents (PCI): This is a less invasive procedure where a doctor threads a thin tube (catheter) through an artery in your wrist or groin up to the heart. A small mesh tube called a stent is expanded to hold the artery open [5].
  • Bypass (CABG): This is a major surgery where a surgeon uses a healthy blood vessel from another part of your body (like your leg or chest) to “bypass” the blocked artery, creating a new path for blood flow [6].

Choosing Based on Evidence

The choice between a stent and a bypass often depends on the complexity of your disease, which is often measured by a tool called the SYNTAX score [7]. The SYNTAX score is one piece of the puzzle, considered alongside left-main anatomy, diabetes, and frailty.

  1. When Stents (PCI) are Preferred:

    • Emergency Situations: PCI is the standard of care for someone having an active heart attack (STEMI), as it can be performed very quickly [8].
    • Lower Complexity: If anatomy is less complex, stents offer excellent results with much faster recovery [9].
    • High Surgical Risk: For patients who are considered too frail for open surgery, PCI may be an alternative [10].

  2. When Bypass (CABG) is Preferred:

    • Diabetes and Multivessel Disease: For patients with diabetes and complex blockages in multiple arteries, bypass surgery is generally more effective at preventing future events [11][12].
    • Complex Anatomy: If the blockages are in difficult locations (like the “Left Main” artery) or are very long, bypass often provides a more durable solution [13][14].
    • Complete Revascularization: If a stent cannot safely reach every necessary area, CABG may be chosen to achieve complete revascularization [15][16].

The Recovery Trade-off and Risks

There is a clear difference in what to expect:

  • PCI Recovery & Risks: Most patients go home within 24–48 hours [17][18]. However, risks include major bleeding, vascular injury, contrast-associated kidney injury, stroke, heart attack, and stent thrombosis [19]. Importantly, if you receive a drug-eluting stent, you will require Dual-Antiplatelet Therapy (DAPT) for a prescribed period; stopping it early can cause a life-threatening clot.
  • CABG Recovery & Risks: Expect a hospital stay of 5 to 7 days and 6 to 12 weeks for a full recovery [18]. Risks of this major surgery include bleeding, infection, atrial fibrillation, stroke, kidney injury, graft failure, and perioperative death [6][20]. Antiplatelet requirements after CABG are different and must also be strictly followed.

Long-Term Comparison

At the 5-year mark, studies show that for most appropriately selected patients, the risk of death or major stroke is similar between the two options [21][22]. However, patients who receive stents are generally more likely to need a “repeat” procedure later on compared to those who have bypass surgery [6][23]. Your Heart Team will help you weigh this short-term convenience against long-term durability.

Common questions in this guide

How do doctors decide between a coronary stent and bypass surgery?
A Heart Team typically considers the location and complexity of the blockages, your SYNTAX score, diabetes status, kidney function, surgical risk, and preferences. The goal is to choose the safest way to restore blood flow and treat all important flow-limiting areas.
Is a stent usually used during an active heart attack?
For an active ST-elevation heart attack (STEMI), PCI with a stent is generally the standard treatment because it can restore blood flow quickly. The exact procedure depends on the emergency team’s assessment and your coronary anatomy.
Why might bypass surgery be recommended for diabetes and multiple blockages?
In people with diabetes and complex disease in several coronary arteries, bypass surgery is generally more effective at preventing future cardiovascular events than stenting. It may also be favored when blockages are difficult to reach or cannot all be treated safely with stents.
How long is recovery after a stent compared with bypass surgery?
After PCI, many patients leave the hospital within 24 to 48 hours. Bypass surgery usually requires a 5- to 7-day hospital stay, with full recovery often taking 6 to 12 weeks.
What complications can happen with stents or bypass surgery?
Stenting can cause bleeding, blood-vessel injury, contrast-related kidney injury, stroke, heart attack, or a clot in the stent. Bypass risks include bleeding, infection, an irregular heart rhythm called atrial fibrillation, stroke, kidney injury, graft failure, and death related to surgery.
Do stents or bypass surgery cure coronary atherosclerosis?
Neither procedure removes the underlying tendency for plaque buildup; each treats selected blockages that limit blood flow. Ongoing medicines and lifestyle changes remain important, and a drug-eluting stent usually requires two prescribed antiplatelet medicines for a set period, which should not be stopped early because of the risk of a dangerous clot.
Are bypass surgery results more durable than stents?
In appropriately selected patients, the risks of death or major stroke are similar between PCI and CABG at about five years. Stents are more likely to require another procedure later, while bypass often offers greater long-term durability in complex disease.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my SYNTAX score and overall anatomy, and how does it influence whether I should have a stent or bypass surgery?
  2. 2.Has my case been reviewed by a multidisciplinary 'Heart Team,' and what was the consensus between the surgeon and the cardiologist?
  3. 3.How does my diabetes (if applicable) or my heart's pumping strength change the long-term success rate of a stent versus a bypass?
  4. 4.If we choose a stent, what is the plan for 'complete revascularization'—can all my significant blockages be safely opened?
  5. 5.What are the specific absolute risks of major complications (like stroke, bleeding, or kidney injury) for me with each procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Revascularization Options: Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention.

    Kappetein AP, van Mieghem NM, Head SJ

    Heart failure clinics 2016; (12(1)):135-9.

    PMID: 26567980
  2. 2

    Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease.

    Tsang MB, Schwalm JD, Gandhi S, et al.

    JAMA network open 2020; (3(8)):e2012749 doi:10.1001/jamanetworkopen.2020.12749.

    PMID: 32777060
  3. 3

    Do the Few Dictate Care for the Many? Revascularisation Considerations That Go Beyond the Guidelines.

    Vervoort D, Sud M, Zeis TM, et al.

    The Canadian journal of cardiology 2024; (40(2)):275-289 doi:10.1016/j.cjca.2023.11.007.

    PMID: 38181974
  4. 4

    Invasive treatment strategies in the ESC guidelines developed in collaboration with EACTS for the management of chronic coronary syndrome: implications for contemporary clinical practice.

    Milojevic M, Micovic S, Otasevic P

    Current opinion in cardiology 2025; (40(6)):382-389 doi:10.1097/HCO.0000000000001253.

    PMID: 40900620
  5. 5

    Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

    Stone GW, Kappetein AP, Sabik JF, et al.

    The New England journal of medicine 2019; (381(19)):1820-1830 doi:10.1056/NEJMoa1909406.

    PMID: 31562798
  6. 6

    Percutaneous coronary intervention with drug-eluting stents versus coronary bypass surgery for coronary artery disease: A Bayesian perspective.

    Kawczynski MJ, Gabrio A, Maessen JG, et al.

    The Journal of thoracic and cardiovascular surgery 2025; (170(2)):558-565.e10 doi:10.1016/j.jtcvs.2024.08.017.

    PMID: 39173709
  7. 7

    SYNTAX Score and Outcomes of Coronary Revascularization in Diabetic Patients.

    Kundu A, Sardar P, O'Day K, et al.

    Current cardiology reports 2018; (20(5)):28 doi:10.1007/s11886-018-0971-1.

    PMID: 29572680
  8. 8

    Diagnosis and Treatment of Acute Coronary Syndromes: A Review.

    Bhatt DL, Lopes RD, Harrington RA

    JAMA 2022; (327(7)):662-675 doi:10.1001/jama.2022.0358.

    PMID: 35166796
  9. 9

    Coronary artery bypass graft surgery versus drug-eluting stent implantation for high-surgical-risk patients with left main or multivessel coronary artery disease.

    Chang M, Lee CW, Ahn JM, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2017; (51(5)):943-949 doi:10.1093/ejcts/ezw370.

    PMID: 28329291
  10. 10

    Modality Selection for the Revascularization of Left Main Disease.

    Tam DY, Bakaeen F, Feldman DN, et al.

    The Canadian journal of cardiology 2019; (35(8)):983-992 doi:10.1016/j.cjca.2018.12.017.

    PMID: 31277888
  11. 11

    Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus.

    Godoy LC, Tavares CAM, Farkouh ME

    Canadian journal of diabetes 2020; (44(1)):78-85 doi:10.1016/j.jcjd.2019.08.002.

    PMID: 31594759
  12. 12

    Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta-analysis.

    Xie Q, Huang J, Zhu K, Chen Q

    Clinical cardiology 2021; (44(7)):899-906 doi:10.1002/clc.23613.

    PMID: 34089266
  13. 13

    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.

    Byrne RA, Fremes S, Capodanno D, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2023; (64(2)) doi:10.1093/ejcts/ezad286.

    PMID: 37632766
  14. 14

    Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.

    Yoon YH, Ahn JM, Kang DY, et al.

    JACC. Cardiovascular interventions 2020; (13(3)):361-371 doi:10.1016/j.jcin.2019.10.020.

    PMID: 32029254
  15. 15

    Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.

    Ahn JM, Park DW, Lee CW, et al.

    JACC. Cardiovascular interventions 2017; (10(14)):1415-1424 doi:10.1016/j.jcin.2017.04.037.

    PMID: 28728654
  16. 16

    Completeness of Revascularization as a Determinant of Outcome: A Contemporary Review and Clinical Perspectives.

    Kwon O, Park DW, Park SJ

    The Canadian journal of cardiology 2019; (35(8)):948-958 doi:10.1016/j.cjca.2018.12.038.

    PMID: 31167712
  17. 17

    Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.

    Madhavan MV, Généreux P, Kirtane AJ, et al.

    European heart journal. Acute cardiovascular care 2017; (6(7)):650-658 doi:10.1177/2048872615592246.

    PMID: 26124455
  18. 18

    Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year-Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS).

    Ganyukov V, Kochergin N, Shilov A, et al.

    Journal of interventional cardiology 2020; (2020()):5458064 doi:10.1155/2020/5458064.

    PMID: 31969796
  19. 19

    Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial.

    Ben-Gal Y, Mohr R, Feit F, et al.

    Circulation. Cardiovascular interventions 2015; (8(6)).

    PMID: 26019142
  20. 20

    Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.

    Park DW, Ahn JM, Park H, et al.

    Circulation 2020; (141(18)):1437-1446 doi:10.1161/CIRCULATIONAHA.120.046039.

    PMID: 32223567
  21. 21

    Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.

    Giacoppo D, Colleran R, Cassese S, et al.

    JAMA cardiology 2017; (2(10)):1079-1088 doi:10.1001/jamacardio.2017.2895.

    PMID: 28903139
  22. 22

    Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

    Head SJ, Milojevic M, Daemen J, et al.

    Journal of the American College of Cardiology 2018; (72(4)):386-398 doi:10.1016/j.jacc.2018.04.071.

    PMID: 30025574
  23. 23

    Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.

    Parasca CA, Head SJ, Milojevic M, et al.

    JACC. Cardiovascular interventions 2016; (9(24)):2493-2507 doi:10.1016/j.jcin.2016.09.044.

    PMID: 28007201

This page is for informational purposes only and does not constitute medical advice. Your cardiologist and cardiac surgeon should assess your coronary anatomy, overall health, and preferences when recommending stents or bypass surgery.

Get notified when new evidence is published on coronary atherosclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.